ONC
BeiGene Ltd - ADR

2,056
Mkt Cap
$34.85B
Volume
292,938.00
52W High
$385.22
52W Low
$196.45
PE Ratio
124.60
ONC Fundamentals
Price
$294.97
Prev Close
$314.36
Open
$299.05
50D MA
$335.69
Beta
0.69
Avg. Volume
268,980.54
EPS (Annual)
$2.54
P/B
7.99
Rev/Employee
$446,430.33
$31,877.75
Loading...
Loading...
News
all
press releases
TD Asset Management Inc Takes $9.33 Million Position in BeOne Medicines Ltd. - Sponsored ADR $ONC
TD Asset Management Inc purchased a new position in BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC - Free Report) in the third quarter, according to the company in its most recent disclosure with...
MarketBeat·6h ago
News Placeholder
More News
News Placeholder
BeOne Medicines (NASDAQ:ONC) Cut to "Buy" at Wall Street Zen
Wall Street Zen lowered shares of BeOne Medicines from a "strong-buy" rating to a "buy" rating in a research report on Saturday...
MarketBeat·3d ago
News Placeholder
BeOne Medicines (NASDAQ:ONC) Stock Price Expected to Rise, Truist Financial Analyst Says
Truist Financial lifted their price objective on shares of BeOne Medicines from $400.00 to $412.00 and gave the company a "buy" rating in a research note on Friday...
MarketBeat·4d ago
News Placeholder
Guggenheim Forecasts Strong Price Appreciation for BeOne Medicines (NASDAQ:ONC) Stock
Guggenheim lifted their price objective on BeOne Medicines from $400.00 to $410.00 and gave the company a "buy" rating in a report on Friday...
MarketBeat·4d ago
News Placeholder
BeOne Medicines (NASDAQ:ONC) Stock Price Expected to Rise, Barclays Analyst Says
Barclays upped their price target on BeOne Medicines from $394.00 to $405.00 and gave the company an "overweight" rating in a research note on Friday...
MarketBeat·4d ago
News Placeholder
Generali Investments Management Co LLC Takes Position in BeOne Medicines Ltd. - Sponsored ADR $ONC
Generali Investments Management Co LLC acquired a new position in shares of BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC - Free Report) in the third quarter, according to its most recent...
MarketBeat·4d ago
News Placeholder
BeOne Medicines (NASDAQ:ONC) Issues Earnings Results
BeOne Medicines (NASDAQ:ONC - Get Free Report) posted its earnings results on Thursday. The company reported $0.58 EPS for the quarter, missing analysts' consensus estimates of $1.60 by ($1.02...
MarketBeat·5d ago
News Placeholder
BeOne Medicines (NASDAQ:ONC) Shares Gap Down Following Weak Earnings
BeOne Medicines (NASDAQ:ONC) Shares Gap Down After Earnings Miss...
MarketBeat·5d ago
News Placeholder
Here's What Key Metrics Tell Us About BeOne Medicines Ltd. - Sponsored ADR (ONC) Q4 Earnings
The headline numbers for BeOne Medicines Ltd. - Sponsored ADR (ONC) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks·5d ago
News Placeholder
BeOne Medicines Ltd. - Sponsored ADR $ONC Stock Holdings Decreased by Primecap Management Co. CA
Primecap Management Co. CA lessened its position in BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC - Free Report) by 0.2% in the 3rd quarter, according to the company in its most recent filing with...
MarketBeat·5d ago
<
1
2
...
>

Latest ONC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.